New York, USA, July 06, 2023 (GLOBE NEWSWIRE) -- Anti-Inflammatory Drugs Global Market to Accelerate at a CAGR of ~6% by 2028 | DelveInsight
The growing frequency of chronic diseases such as asthma, arthritis, chronic obstructive pulmonary disease (COPD), and others is driving up demand for anti-inflammatory drugs. Furthermore, increasing research on anti-tumor necrosis factor (TNF), interleukins, Janus kinase inhibitors, anti-inflammatory biologics, immune selective anti-inflammatory derivatives (ImSAIDs), and others, as well as the rising prevalence of auto-immune diseases, increased focus on developing biosimilars, and increased drug launches and approvals globally, are all contributing to the overall growth of the anti-inflammatory drugs market.
DelveInsight’s Anti-Inflammatory Drugs Market Insights report provides the current and forecast market analysis, individual leading anti-inflammatory drugs companies’ market shares, challenges, anti-inflammatory drugs market drivers, barriers, trends, and key market anti-inflammatory drugs companies in the market.
Key Takeaways from the Anti-Inflammatory Drugs Market Report
- As per DelveInsight estimates, North America is anticipated to dominate the global anti-inflammatory drugs market during the forecast period.
- Notable anti-inflammatory drugs companies such as Amgen Inc., Sun Pharmaceutical Industries Ltd., Johnson & Johnson Services, Inc., Pfizer Inc., Medical Device Business Services, Inc., Novartis AG, GSK plc., F. Hoffmann-La Roche Ltd, AbbVie Inc., AstraZeneca, Merck & Co., Inc., Lilly., Bristol-Myers Squibb Company, Biogen, Aurobindo Pharma, Reckitt Benckiser Group PLC., Dr. Reddy’s Laboratories Ltd., Sanofi, Strides Pharma Science Limited, Heron Therapeutics, Inc., and several others, are currently operating in the anti-inflammatory drugs market.
- In August 2022, Strides Pharma Global Pte Ltd received approval from the US health regulator for generic naproxen sodium soft gel capsules, used to treat pain or inflammation.
To read more about the latest highlights related to the anti-inflammatory drugs market, get a snapshot of the key highlights entailed in the Global Anti-Inflammatory Drugs Market Report
Anti-Inflammatory Drugs Overview
An anti-inflammatory therapeutic is a medicine that relieves acute and chronic pain as well as inflammation (redness, swelling, and pain). Anti-inflammatory drugs prevent the body from producing molecules that cause inflammation. They are used to treat a variety of ailments including migraines, headaches, rheumatoid arthritis, sprains, and menstruation discomfort. Furthermore, some anti-inflammatory drugs, such as celecoxib and ibuprofen, are being researched for cancer prevention and treatment. Furthermore, as compared to other medications, they can provide speedier relief. They have the ability to reduce the amounts of prostaglandins and the substances responsible for inflammation, so reducing pain and swelling. Anti-inflammatory medications usually target anti-inflammatory mediators or enzymes. These meds are frequently used with other medications.
Anti-Inflammatory Drugs Market Insights
North America is expected to account for the highest proportion of the global anti-inflammatory drugs market in 2023, out of all regions. This dominance is due to rising chronic pain and rising adoption of NSAIDs in headaches, migraines, toothaches, menstrual pain, and others, increasing drug launch and approvals by market players, established healthcare sector with a large number of renowned players, high investment & demand for more effective and safer drugs, high income per capita, rise in patient visits to physicians, and research advancements due to high funding, among other factors, will propel the anti-inflammatory drugs market.
To know more about why North America is leading the market growth in the anti-inflammatory drugs market, get a snapshot of the Anti-Inflammatory Drugs Market Outlook
Anti-Inflammatory Drugs Market Dynamics
The anti-inflammatory drugs market is expanding due to a variety of factors, one of which is the growing global burden of chronic pain and inflammation. Furthermore, leading pharmaceutical companies focused on developing biosimilar-related anti-inflammatory drugs are projected to grow the anti-inflammatory drugs market. Furthermore, the expiration of the patents on the major anti-inflammatory biologics prepared the way for biosimilars to join the market. Several manufacturers have shifted their focus to biosimilars due to increased demand and a faster approval process than for new medications. This has evolved into a huge anti-inflammatory drugs market trend. Biosimilars of adalimumab, infliximab, and etanercept compete with Humira, Remicade, and Enbrel, three biologics with significant market revenue potential.
The FDA has approved five Humira biosimilars, all of which are expected to be available in the US in 2023. While the adalimumab biosimilar is now accessible commercially in other areas, such as Europe. Furthermore, clinical research has already begun to develop biosimilar versions of reference biologics that will shortly lose exclusivity. This is expected to raise demand for anti-inflammatory drugs in the future years.
However, pharmacological side effects, complex regulatory procedures, and other factors may limit the expansion of the anti-inflammatory drugs market.
Get a sneak peek at the anti-inflammatory drugs market dynamics @ Anti-Inflammatory Drugs Market Dynamics Analysis
| Report Metrics | Details |
| Coverage | Global |
| Study Period | 2020–2028 |
| Anti-Inflammatory Drugs Market CAGR | ~6% |
| Key Anti-Inflammatory Drugs Companies | Amgen Inc., Sun Pharmaceutical Industries Ltd., Johnson & Johnson Services, Inc., Pfizer Inc., Medical Device Business Services, Inc., Novartis AG, GSK plc., F. Hoffmann-La Roche Ltd, AbbVie Inc., AstraZeneca, Merck & Co., Inc., Lilly., Bristol-Myers Squibb Company, Biogen, Aurobindo Pharma, Reckitt Benckiser Group PLC., Dr. Reddy’s Laboratories Ltd., Sanofi, Strides Pharma Science Limited, Heron Therapeutics, Inc., among others |
Anti-Inflammatory Drugs Market Assessment
- Anti-Inflammatory Drugs Market Segmentation
- Anti-Inflammatory Drugs Market Segmentation By Drug Class: Anti-Inflammatory Biologics, Nonsteroidal Anti-Inflammatory Drugs (NSAIDS), Immune-Selective Anti-Inflammatory Derivative (IMSAID), Corticosteroids, and Others
- Anti-Inflammatory Drugs Market Segmentation By Indication: Arthritis, Asthma, Inflammatory Bowel Disease (IBD), Chronic Obstructive Pulmonary Disease (COPD), Multiple Sclerosis, and Others
- Anti-Inflammatory Drugs Market Segmentation By Sales Channel: Prescription and Over The Counter (OTC)
- Anti-Inflammatory Drugs Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
Which MedTech key players in the anti-inflammatory drugs market are set to emerge as the trendsetter explore @ Anti-Inflammatory Drugs Companies
Table of Contents
| 1 | Report Introduction |
| 2 | Executive summary |
| 3 | Regulatory and Patent Analysis |
| 4 | Key Factors Analysis |
| 5 | Porter’s Five Forces Analysis |
| 6 | COVID-19 Impact Analysis on Anti-Inflammatory Drugs Market |
| 7 | Anti-Inflammatory Drugs Market Layout |
| 8 | Global Company Share Analysis – Key 3-5 Companies |
| 9 | Anti-Inflammatory Drugs Market Company and Product Profiles |
| 10 | Project Approach |
| 11 | About DelveInsight |
Interested in knowing the anti-inflammatory drugs market by 2028? Click to get a snapshot of the Anti-Inflammatory Drugs Market Trends
Related Reports
Psoriatic Arthritis Market Insights, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key psoriatic arthritis companies including UCB Biopharma, Formycon, Bristol-Myers Squibb, AbGenomics, Boehringer Ingelheim, Affibody, AltruBio, Bio-Thera Solutions, among others.
Psoriasis Pipeline Insight – 2023 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key psoriasis companies, including Mylan, Biocad, Bristol-Myers Squibb, Celltrion, Coherus BioSciences, Janssen Pharmaceuticals, Can-Fite Biopharma, Arcutis Biotherapeutics, Amgen, Iltoo Pharma, GlaxoSmithKline, Galectin Therapeutics, Evelo Biosciences, Galderma, BioMimetix JV, Menlo Therapeutics Inc., Aristea Therapeutics, UNION Therapeutics, MetrioPharm, Sienna Biopharmaceuticals, among others.
Psoriasis Market Insights, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key psoriasis companies, including Mylan, Biocad, Bristol-Myers Squibb, Celltrion, Coherus BioSciences, Janssen Pharmaceuticals, Can-Fite Biopharma, Arcutis Biotherapeutics, Amgen, Iltoo Pharma, GlaxoSmithKline, Galectin Therapeutics, Evelo Biosciences, Galderma, BioMimetix JV, Menlo Therapeutics Inc., Aristea Therapeutics, UNION Therapeutics, MetrioPharm, Sienna Biopharmaceuticals, among others.
Rheumatoid Arthritis Market Insights, Epidemiology, and Market Forecast – 2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key rheumatoid arthritis companies including Taisho Pharmaceutical, Zhejiang Hisun Pharmaceutical, SinoMab, Jiangsu Hengrui Medicine, RemeGen, GlaxoSmithKline, Modern Biosciences, Jiangsu Alphamab Biopharmaceuticals, Akros Pharma, Hanlim Pharm, Galapagos NV, Chong Kun Dang Pharmaceutical, Bristol Myers Squibb, AstraZeneca, Aclaris Therapeutics, Abivax, AbbVie, Synact Pharma, Gilead sciences, Mesoblast, Rottapharm Biotech, Eli Lilly and Company, Kiniksa Pharmaceuticals, Abcentra, Cyxone, Yungjin Pharm. Co., Ltd. Taiho Pharmaceutical, Oscotec Inc., Pfizer, Janssen Research & Development, Cipher Pharmaceuticals Inc., KLUS Pharma Inc., Revolo Biotherapeutics, Lynk Pharmaceuticals, Beijing Baylx Biotech, Hope Biosciences, Kangstem Biotech, Celltex Therapeutics, I-Mab Biopharma Co. Ltd., Synermore Biologics Co., Ltd, Oryn Therapeutics, Arthrogen, Amgen, Biozeus, Landos Biopharma, Imcyse, Kymera Therapeutics, RedHill Biopharma, 4D Pharma, CV6 Therapeutics, VYNE Therapeutics, MyMD Pharmaceuticals, Brickell Biotech Inc, Worg Pharmaceuticals, Almirall, Standigm, Metrion Biosciences, Jnana Therapeutics, Silo Pharma, SFA Therapeutics, Neutrolis Therapeutics, Ahead Therapeutics, Fresenius Kabi, Kidswell Bio, BioXpress Therapeutics, CinnaGen, Alvotech, Hetero Biopharma, Shanghai Henlius Biotech, Cadila Pharmaceuticals, Innovent Biologics, Torrent Pharmaceuticals, Emcure Pharmaceuticals, mAbxience, Shanghai Junshi Biosciences, Enosi Therapeutics, among others.
Osteoporosis Market Insights, Epidemiology, and Market Forecast – 2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key osteoporosis companies including Shanghai JMT-Bio Inc., Transcenta Holding, Celltrion, Teva Pharmaceuticals, Enzene Biosciences, Fresenius Kabi, Gedeon Richter, Samsung Bioepis, Alvotech, MAbxience, Shanghai Henlius Biotech, Rani therapeutics, Entera Bio, Paras Biopharmaceuticals, Shenzhen Salubris Pharmaceutical, Enteris Biopharma, Prestige Biopharma, Shinpoong Ltd., Shanghai Biomabs Pharmaceutical, Jiangsu HengRui Medicine Co., Ltd., Angitia Biopharmaceuticals, Dongkook pharmaceutical, Luye Pharma Group, Biocon Biologics UK Ltd, Bonus BioGroup Ltd., Cellatoz Therapeutics, Inc., Keros Therapeutics, Clayton Biotechnologies, Novadip, Eli Lilly and company, Hexal, Sandoz, Solarea Bio, among others.
Other Trending Reports
Image Guided Surgery Devices Market | Alopecia Market | Chronic Myelogenous Leukemia Market | Neuroblastoma Market | Alzheimer Disease Market | Osteoarthritis Market | Apheresis Market | Scleroderma Market | Hyperhidrosis Market | Opioid Induced Constipation Market | Cervical Intraepithelial Neoplasia Market | Automated External Defibrillators Market | Choroidal Neovascularization Market | Familial Primary Pulmonary Hypertension Market | Meningioma Market | Progressive Multifocal Leukoencephalopathy Market | Chemotherapy Induced Thrombocytopenia Market | Deep Vein Thrombosis Market | Duchenne Muscular Dystrophy Market | Human Papilomavirus Market | Myelofibrosis Market | Postsurgical Pain Market | Stable Angina Market | Trigeminal Neuralgia Market Size | Adult Growth Hormone Deficiency Market | Allergic Rhinitis Market | Angioedema Market | Chronic Inflammtory Demyelinating Polyneuropathy Market | Chronic Lymphocytic Leukemia Cll Market | Colorectal Cancer Market | Encephalitis Market | Rett Syndrome Market | Xerostomia Market | Carpal Tunnel Syndrome Market | Cluster Headache Market | Global Electrophysiology Devices Market | Pharma Licensing Services | Pressure Ulcers Market Size | Blood Gas And Electrolyte Analyzers Market | Chronic Lymphocytic Leukemia Market | Minimal Residual Disease Market | Acute Coronary Syndrome Market | Age-Related Macular Degeneration Market | Ankylosing Spondylitis Market | Contraceptive Devices Market | Eczema Market | Hemodynamic Monitoring Systems Market | Intracranial Pressure Monitoring Devices Market | NCFB Market | Vertigo Market | Nsclc Market | Prefilled Syringes Market | Multiple Myeloma Market | Parkinson's Disease Market | Actinic Keratosis Market | Allergic Conjunctivitis Market | Cervical Cancer Market Size | Concussions Market Size | Neurovascular Devices Market | Ventilator Market
Related Healthcare Services
Healthcare Competitive Intelligence Services
Healthcare Asset Prioritization Services
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
